“…Avoiding placing severely immunosuppressed patients in rooms with other patients is generally preferred. Cohorting has been extensively used for managing outbreaks of MDROs, including MRSA, 22, 806 VRE, 637,807,808 MDR-ESBL, 809 P aeruginosa, 29 MSSA, 810 RSV, 811,812 adenovirus keratoconjunctivitis, 813 rotavirus, 814 and SARS. 815 Modeling studies provide additional support for cohorting patients to control outbreaks; [816][817][818] however, cohorting often is implemented only after routine infection control measures have failed to control an outbreak.…”